Insulin resistance and thyroid disorders

Endokrynologia Polska

Volumn 65, Issue 1, 2014, Pages 70-76

  Gierach, Marcin ^a   Gierach, Joanna ^a   Junik, Roman ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Hyperthyroidism; Hypothyroidism; Insulin resistance; Thyroid disorders

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; THYROID HORMONE;

ADIPOCYTE; ARTICLE; DISORDERS OF CARBOHYDRATE METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIVER CELL; SKELETAL MUSCLE; SUBCLINICAL HYPERTHYROIDISM; THYROID DISEASE; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM;

DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; THYROID DISEASES; THYROID HORMONES;

EID: 84896724486     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: 10.5603/EP.2014.0010     Document Type: Article

References (36)

1. Wesolowski P, Wankowicz Z. Insulinoopornosc - metody rozpoznawania i nastepstwa kliniczne. Nephrol Dial Pol 2011; 15: 243-246.
2. Grzesiuk W, Szydlarska D, Józwik K. Insulinoopornosc w endokrynopataich. Endokrynol Otyl Zab Przem Mat 2008; 5: 38-44.
3. Dimitriadis G, Maratou E, Boutati E et al. Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry. Cytometry A 2005; 64: 27-33.
4. Maratou E, Hadjidakis D, Peppa M et al. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur J Endocrinol 2010; 163: 625-630.
5. Dimitriadis G, Maratou E, Boutati et al. IGF-1 increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism. Eur J Endocrinol 2008; 158: 361-366.
6. Maratou E, Hadjidakis DJ, Kollias A et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009; 160: 785-790.
7. Dimitriadis G, Maratou E, Alevizaki M et al. Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface. Horm Metab Res 2005; 37: 15-20.
8. Dimitriadis G, Mitrou P, Lambadiari V et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol and Metab 2006; 91: 4930-4937.
9. Szurkowska M, Szafraniec K, Gilis-Janiuszewska A et al. Wskazniki insulinoopornosci w badaniu populacyjnym i ich wartosc predykcyjna w okresleniu zespolu metabolicznego. Przeglad Epidemiologiczny 2005; 59: 743-751.
10. Handisurya A, Pacini G, Tura A et al. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol 2008; 69: 963-969.
11. Krassowski J. Tolerancja glukozy w endokrynopatiach. Diabetologia Praktyczna 2004; 5: 51-55.
12. Chubb SA, Davis WA, Inman Z et al. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin Endocrinol 2005; 62: 480-486.
13. Dimitriadis G, Raptis S. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes 2001; 109 (Suppl. 2): S225-S239.
14. Dimitriadis G, Mitrou P, Lambadiari V et al. Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. J Clin Endocr Metab 2008; 93: 2413-2415.
15. Calxas A, Tirado R, Vendrell J et al. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters. Clin Endocrinol 2009; 71: 733-738.
16. Donckier JE: Endocrine diseases and diabetes. W: Pickup J.C., Williams G. (red.). Textbook of diabetes. Blackwell Publishing 2003: 27.1-27.15.
17. Brenta G. Why can insulin resistance be a natural consequence of thyroid dysfunction? J Thyroid Res 2011; 7: 1-9.
18. Mitrou P, Boutati E, Lambadiari V et al. Insulin resistance in hypothyroidism: the role of IL-6 and TNF alfa. Eur J Endocrin 2010; 162: 121-126.
19. Yavoz DG, Yuksel M, Deyneli O et al. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Clin Endocrinol 2004; 61: 515-521.
20. Rezzonico J, Niepomniszcze H, Rezzonico M et al. The association of insulin resistance with subclinical thyreotoxicosis. Thyroid 2011; 21: 945-949.
21. Yavuz DG, Yazici D, Toprak A et al. Exogenous subclinical hyperthyroidism impairs endothelial function in nodular goiter patient. Thyroid 2008; 18: 395-400.
22. Roos A, Bakker SJ, Links TP et al. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocr Metab 2007; 92: 491-496.
23. Rochon C, Tauveron I, Dejax C et al. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci 2003; 104: 7-15.
24. Cettour-Rose P, Theander-Carillo C, Asencio C et al. Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia 2005; 48: 624-633.
25. Pujanek M, Bronisz A, Malecki P et al. Pathomechanisms of The development of obesity in some endocrinopathies - an overview. Endokrynol Pol 2013; 63: 150-155.
26. Tamer G, Mert M, Tamer I et al. Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia. Endokrynol Pol 2011; 62: 421-428.
27. Stanicka S, Vondra K, Pelikanova T et al. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy. Clin Chem Lab Med 2005; 43: 715-720.
28. Brenta G, Celi F, Pisarev M et al. Acute thyroid hormone withdrawal in athyreotic patients results in a state of insulin resistance. Thyroid 2009; 19: 665-669.
29. Owecki M, Nikisch E, Sowinski J. Hypothyroidism has no impact on insulin sensitivity assessed with HOMA-IR in totally thyroidectomized patients. Acta Clin Belg 2006; 61: 69-73.
30. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004; 24: 1-13.
31. Rodondi N, Aujesky D, Vittinghoff E et al. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med 2006; 119: 541-551.
32. Singh S, Duggal J, Molnar J et al. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Intern J Cardiol 2008; 125: 41-48.
33. Dessein PH, Joffe BI, Stanwix AE. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid. 2004; 14: 443-446.
34. Brenta G, Berg G, Arias P et al. Lipoprotein alterations, hepatic lipase activity and insulin sensitivity in subclinical hypothyroidism: response to L-T4 treatment. Thyroid 2007; 17: 453-460.
35. Al Sayed A, Al Ali N, Bo Abbasy et al. Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women. Endocrine 2006; 53: 653-657.
36. Tuzcu A, Bahceci M, Gokalp D et al. Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. J Endocrinol 2005; 52: 89-94.